EKF Diagnostics Holdings plc

Equities

EKF

GB0031509804

Advanced Medical Equipment & Technology

Market Closed - London S.E. Other stock markets 16:35:07 17/05/2024 BST			5-day change	1st Jan Change
33 ^GBX	0.00%		+8.91%	+4.27%

05-15	Future Metals celebrates state government grant	AN
05-14	EKF Diagnostics Holdings Says Q1 Adj EBITDA Shows About 20% Improvement	RE

EKF Diagnostics Holdings plc Provides Earnings Guidance for the Year Ended December 31, 2017

January 11, 2018 at 07:00 am

EKF Diagnostics Holdings plc provided earnings guidance for the year ended December 31, 2017. For the year, the company reported revenues for the year ended 31 December 2017 are in line with expectations whilst adjusted EBITDA is expected to comfortably exceed expectations. Net cash at the yearend is £6.8 million.

Latest news about EKF Diagnostics Holdings plc

Future Metals celebrates state government grant	05-15	AN
EKF Diagnostics Holdings Says Q1 Adj EBITDA Shows About 20% Improvement	05-14	RE
Onward Opportunities' small-cap strategy yields solid results in 2023	04-11	AN
EKF Diagnostics says prospects "promising" but pauses dividends	03-20	AN
EKF Diagnostics Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2023	03-20	CI
EKF Diagnostics reports trading in line with expectations	01-29	AN
EKF Diagnostics Holdings plc Provides Earnings Guidance for the Full Year 2023	01-29	CI
EKF Diagnostics Holdings plc Announces the Official Opening of its New State-Of-The-Art Life Sciences Manufacturing Site in South Bend, Indiana, United States	26/10/23	CI
EARNINGS: FireAngel Safety interim loss widens amid ongoing headwinds	26/09/23	AN
Earnings Flash (EKF.L) EKF DIAGNOSTICS HOLDINGS Reports H1 Revenue GBP26.9M	26/09/23	MT
EKF Diagnostics Holdings plc Reports Earnings Results for the Half Year Ended June 30, 2023	26/09/23	CI
FTSE 100 Closes Tuesday Up 0.41% as Oil-Price Rises Benefit the Index	12/09/23	DJ
EKF Diagnostics hires CFO from Trellus Health, latter names successor	12/09/23	AN
FTSE 100 Rises, Led by AB Foods; Smurfit Kappa Slides	12/09/23	DJ
Trellus Health's Interim Finance Head Takes Full-time CFO Role at EKF Diagnostics	12/09/23	MT
EKF Diagnostics Holdings plc Provides Financial Guidance for the Year Ending 31 December 2023	12/09/23	CI
EKF Diagnostics Holdings plc Appoints Stephen Young as Chief Financial Officer	12/09/23	CI
Revolution Bars reports good progress from Peach Pubs	26/07/23	AN
FTSE 100 Closes Down 0.2% as Miners Offset Ocado, -2-	26/07/23	DJ
FTSE 100 Closes Up 0.5% as Sage Group Shines	28/06/23	DJ
SONIA Illiquidity Could Explain Disconnect in BOE Peak Rate Pricing	28/06/23	DJ
EKF Diagnostics says CFO Davies resigns to pursue other opportunities	28/06/23	AN
EKF Diagnostics CFO Plans Exit; Successor to Assume Role in Q4	28/06/23	MT
Marc Davies to Step Down as Chief Financial Officer of EKF Diagnostics Holdings plc	28/06/23	CI
EKF Diagnostics announces enzyme fermenter progress	20/06/23	AN

Chart EKF Diagnostics Holdings plc

Duration

Period

More charts

Company Profile

EKF Diagnostics Holdings plc is a United Kingdom-based diagnostics company. The Company is engaged in point-of-care testing, central laboratory tests, enzyme manufacturing and the provision of contract manufacturing services to the healthcare industry. Its principal activity is the development, manufacture and supply of products into the in-vitro diagnostics marketplace. Its point of care analyzers is designed for use within doctors' surgeries, clinics, blood banks and hospital and private laboratories to provide results. Its life sciences specialize in producing enzymes and contracted custom products for use in medical diagnostics, pharmaceuticals and industry. Its life science facilities are based in two locations in Indiana, United States. Its central laboratory division manufactures a spectrum of reagents for use in hospital laboratories. Its contract manufacturing business provides specialized services to the diagnostics and healthcare industries for the production of custom kits.

Sector

Advanced Medical Equipment & Technology

Calendar

09/09/2024 - Q2 2024 Earnings Release (Projected)

More about the company